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Type III secretion systems are complex nanomachines used
for injection of proteins from Gram-negative bacteria into
eukaryotic cells. Although they are assembled when the envi-
ronmental conditions are appropriate, they only start secreting
upon contact with a host cell. Secretion is hierarchical. First, the
pore-forming translocators are released. Second, effector pro-
teins are injected. Hierarchy between these protein classes is
mediated by a conserved gatekeeper protein, MxiC, in Shigella.
As its molecular mechanism of action is still poorly understood,
we used its structure to guide site-directed mutagenesis and
to dissect its function. We identified mutants predominantly
affecting all known features of MxiC regulation as follows:
secretion of translocators, MxiC and/or effectors. Using molec-
ular genetics, we then mapped at which point in the regulatory
cascade the mutants were affected. Analysis of some of these
mutants led us to a set of electron paramagnetic resonance
experiments that provide evidence that MxiC interacts directly
with IpaD.We suggest how this interaction regulates a switch in
its conformation that is key to its functions.
Type III secretion systems (T3SSs)5 are central devices in the
virulence of many major Gram-negative bacterial pathogens of
humans, animals, and plants. They translocate virulence pro-
teins into the membranes and cytoplasm of eukaryotic host
cells to manipulate them during infection. T3SSs are key to the
virulence of enteric pathogens such as Escherichia coli, Salmo-
nella, and Shigella species.
Shigella species are the etiological agent of bacillary dysen-
tery in humans (1). The ShigellaT3SS consists of a cytoplasmic
portion and a transmembrane region traversing both bacterial
membranes, into which a hollow needle, made of MxiH, is
embedded protruding from the bacterial surface (2). Physical
contact with eukaryotic host cells activates the secretion sys-
tem, which initiates secretion and leads to creation of a pore,
formed by the bacterial proteins IpaB and IpaC, in host cell
membranes (3). The effectors are translocated through the nee-
dle (4) and pore channels to facilitate host cell invasion (3). The
needle tip complex (TC), which contains IpaD and IpaB, is the
host cell sensor and transforms itself into the translocation pore
(5) via addition of IpaC upon secretion activation (6, 7). IpaD is
hydrophilic and required for tip recruitment of the other two
proteins, which are hydrophobic, and hence chaperoned by
IpgC intrabacterially (8). The three proteins are collectively
called the translocators.
T3SSs are assembled, using a broadly conservedmorphogen-
esis pathway (9), following detection of environmental cues
indicating entry into the host. In addition, virulence effectors
acting late in the host cell manipulation cascade are only
expressed once the presynthesized early effectors have been
secreted at host cell contact. Most components and/or molec-
ular mechanisms of these regulatory pathways diverge from
one T3SS-carrying organism to another (10). However, one
regulatory cascade is conserved, a process allowing hierarchical
secretion of substrates, although the stages it covers vary as
follows: needle versus translocator components in plant patho-
gens or translocators and then early effectors in animal ones
(11).
Here, we focus on how this cascade functions in animal
pathogens. After T3SS assembly, effector secretion is prevented
through the concerted action of surface TC proteins and regu-
lators that control secretion from within the bacterial cyto-
plasm. The TC may prevent premature effector secretion by
allosterically constraining the T3SS in a secretion “off” confor-
mation without blocking the secretion channel (12–14). Upon
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physical contact of the TC with host cells, a signal, termed Sig-
nal 1, is transmitted via the TC (15) and needle (12, 16) to the
cytoplasm where it triggers secretion. Next, translocators are
secreted to form the pore in the host cell membrane (3). Suc-
cessful pore formation at the needle tip generates Signal 2, also
transmitted via the needle, that allows inactivation or T3S-me-
diated removal of a conserved cytoplasmic regulatory protein
MxiC in Shigella (12, 16). Then the early effector proteins are
secreted and translocated into the host cell, and late effector
expression is activated (17).
MxiC belongs to a class of “gatekeeper” proteins that is con-
served among different type III secretion systems (18). They
repress effector secretion in the absence of a secretion signal
but have different roles in translocator secretion, impairing it in
a mxiC mutant (12) while stimulating it in a Yersinia yopN
mutant (19). Although gatekeepers are clearly involved in the
cytoplasmic steps controlling T3SS secretion hierarchy upon
activation, their mechanism of action remains unclear.
The gatekeepers have conserved structures (20, 21). After an
N-terminal secretion signal and putative chaperone-binding
domain (CBD), three -helical X-bundles (domains 1–3; see
supplemental Fig. S1,A–C) form a flat, elongated structure (21)
typical for “hub proteins” regulating processes via interaction
with multiple partners. In some species, gatekeepers are com-
posed of two proteins where the second polypeptide covers the
C-terminal X-bundle (domain 3; supplemental Fig. S1,D andE)
(20).
MxiC is secreted by the type III secretion system (22). Its
N-terminal 30 residues contain the secretion signal (23). Imme-
diately thereafter is a domain similar to the chaperone-binding
domain of YersiniaYopN (20, 21). This domain is partially con-
served (18) even though not every MxiC homolog has an iden-
tified chaperone. Although this area is enriched in hydrophobic
residues that mediate interactions with the chaperones, fewer
hydrophobic residues are found in MxiC.
Many type III secreted proteins are bound by a chaperone
inside the bacterium. These chaperones have various roles,
including stabilization of their binding partners, aiding their
secretion and mediation of secretion hierarchy (24). Several
MxiC homologs bind to specific heterodimeric chaperones. For
instance, Yersinia YopN binds to the SycN/YscB heterodimer
(20, 25). It wraps around its heterodimeric chaperone in a con-
formation similar to other effector-chaperone complexes (20).
This domain is disordered in the absence of the chaperones.
Interestingly, the first75 residues ofMxiC are also likely to be
disordered (21). Yet, so far no chaperone has been identified for
MxiC (23).
MxiC’s helix 9 of is a straight helix, although the structurally
equivalent helix in YopN/TyeA is kinked into two smaller heli-
ces. The structure of the EPEC MxiC homolog, SepL, is also
bent at an equivalent location (26). Thus, one face of the mole-
cule is flat in MxiC, although it is concave in YopN/TyeA and
SepL (21, 26). Interestingly, this surface contains a negatively
charged patch (Glu-201, Glu-276, and Glu-293 (21)) that we
showed is important forMxiC functions that involve IpaD (15).
Furthermore, the Chlamydia hydrophobic translocator chap-
erone Scc3 binds to its gatekeeper at the flat interface between
domains 2 and 3 (27), which the kink in theYopN/TyeA renders
convex. Deane et al. (21) already suggested this structural dif-
ference betweenMxiC and YopN/TyeA could be a “conforma-
tional switch,” and these new findings suggest itmight allow the
switch fromhydrophilic to hydrophobic translocator secretion.
To dissect MxiC’s interconnected functions, we used site-
directed mutagenesis. Mutant design was guided by the
description of MxiC structure by Deane et al. (21) and the
sequence alignment ofMxiChomologs by Pallen et al. (18).Our
mutations (Fig. 1) focused on the N-terminal non-crystallized
region and domains 2 and 3 of the crystal structure (21). We
identified mutants predominantly affecting all known features
ofMxiC regulation as follows: secretion of translocators,MxiC,
and effectors. Using molecular genetics to map at which point
in the regulatory cascade the mutants were affected, we further
dissectedMxiC’s role. Analysis of some of these mutants led us
to electron paramagnetic resonance (EPR) experiments that,
together with phenotypic analysis of the mutants, provide evi-
dence that MxiC’s conformation is regulated via a direct inter-
action with IpaD.
Results
MxiC’s Secretion Signal Is Not Required for Promoting Induc-
ible Translocator Secretion—A non-secretable form of MxiC
lacking residues 2–30 is unable to prevent effector secretion
(23). However, MxiC also regulates inducible translocator
secretion (12). This had not yet been characterized when the
mxiCNtermmutant was first described.We thus investigated
whether MxiC’s two roles could be uncoupled.
We generated anmxiCNtermmutant equivalent to that of
Botteaux et al. (23). In our hands, MxiCNterm was unstable,
whereas wild-type mxiC was induced to wild-type levels after
addition of 25 M IPTG, andmxiCNterm was only expressed
at similar levels after addition of 100 M IPTG. Furthermore,






FIGURE 1. Location of MxiC mutations used in this work. Top, MxiC struc-
ture 2VJ4 (chain A) colored from blue at the N terminus, whereMxiC Cys-74 is
the first residue in the first crystallized helix, to red at the C terminus (Cterm).
Therefore, the N terminus and most of CBD are not shown. Bottom, same as
MxiC rotated by 90° about its long axis. Mutated residues are colored accord-
ing to their design group, as labeled on the figure. Orange indicates muta-
tions in the hydrophobic core of the protein, made by others (19, 33), which
lead to loss of function. Neg, negative; hydro, hydrophobic.
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As described previously, MxiCNterm is not secreted after
Congo red (CR) induction (Fig. 2A) (23) and effector proteins
are leaked (data not shown) (23). Furthermore, MxiCNterm
was not secreted in a ipaB constitutive secretor background
(supplemental Fig. S2), indicating deletion of the N terminus
affects its ability to become secreted. However, secretion of
IpaB, IpaC, and IpaD was unaffected in mxiCNterm; small
differences between mxiC/mxiC and mxiCNterm were
not statistically significant (Fig. 2, A and C). Thus, the ability of
MxiC to prevent effector secretion and to promote inducible
translocator secretion are not coupled, and only the former
requires its secretion signal.
MxiC’s C Terminus Is Essential—The 11 C-terminal residues
of the EPECMxiChomolog, SepL, are required for regulation of
effector secretion but not for translocator secretion (28). As a
complementary experiment, we deleted the last 14 residues of
MxiC (Fig. 1, bottom), which are equivalent to the last 11 resi-
dues of SepL (supplemental Fig. S3) (18). The resulting
mxiCCtermmutant was stably expressed but unable to com-
plementmxiC (supplemental Fig. S4); translocators were only
weakly induced, and effector proteins were leaked. In addition,
MxiCCterm itself was only poorly secreted (supplemental Fig.
S4) even in ipaB (supplemental Fig. S2). Therefore, unlike for
SepL, MxiC’s C terminus is essential.
Putative Chaperone-binding Domain of MxiC Regulates Its
Secretion and Hence That of the Effectors—The chaperone-
binding domain of YopN has a chaperone-independent role in
secretion regulation (29). We thus wondered whether MxiC’s
putative chaperone-binding domain is required for its function.
First, we deleted the whole CBD (Fig. 1, top) to generate
mxiCCBD, lacking residues 32–72. This construct was stably
expressed, but it was leaked and only weakly secreted upon CR
induction (Fig. 3A). Interestingly, secretion of MxiCCBD was
enhanced in a ipaB background (supplemental Fig. S2). This
indicates the chaperone-binding domain influences the regula-
tion of MxiC secretion rather than the intrinsic ability of the
protein to become secreted. Furthermore, although mxiC
CBD could not block effector secretion, it was able to promote
translocator secretion (Fig. 3A).
Next, we investigated which YopN residues contacting the
chaperones are conserved in MxiC. As the alignment of this
area is ambiguous (supplemental Fig. S5), we made several sin-
gle and combined charge-swap mutations. mxiCK66E was
unable to complement mxiC. Paradoxically, the mutant pro-
tein was detected in culture supernatants and, to a lesser
degree, in the supernatants after CR induction, but only low
levels were detected in whole culture lysates (Fig. 3C).
mxiC(D46K,D49K) had a wild-type-like phenotype, except for
some premature MxiC secretions. mxiC(D46K,D49K,K66E)
leaked MxiC at high levels and was unable to prevent effector
secretion (data not shown). A similar phenotype was observed
inmxiCK68E (Fig. 3). Furthermore,mxiCK68E andmxiCK66E,
but notmxiCCBD, displayed reduced induction of transloca-
tor secretion, suggesting the effect of the point mutations on
translocator secretion is indirect. Therefore, the putative chap-
erone-binding domain is required for regulating MxiC secre-
tion and for preventing effector secretion.
MxiC lacking its secretion signal is not secreted and is also
unable to prevent effector secretion (23). In an mxiHK69A
mutant where MxiC is not secreted, effectors are also not
released (12, 16). Thus, there is a correlation between “secret-
ability” and the ability to block secretion. We hence tested
whether MxiC needs to be quantitatively removed from the
cytoplasm to release the block on effector secretion. We com-
pared the levels of several secreted proteins in supernatants
after induction with CR with levels in the corresponding total
cultures, i.e. samples containing secreted and intracellular pro-
teins. The translocators IpaB and IpaC were secreted nearly
completely, whereas only 8  6% of MxiC was secreted in the













































































FIGURE 2.MxiCwithout its secretion signal is still able to promote induc-
ible translocator secretion. A, protein secretion in response to the artificial
inducer CR. Samples from Shigella wild type, mxiC mutant, complemented
strain (mxiC/mxiC, grownwith25M IPTG), andmxiCNterm (in themxiC
background, grown with 100 M IPTG) were collected as described under
“Experimental Procedures,” silver-stained (top panel), and Western-blotted
with the indicated antibodies (bottom panels). All samples probed with the
same antibody were analyzed on the same gel. Results shown are represen-
tative of at least two independent experiments. B, total protein expression
levels in whole culture lysates. Samples were collected as described under
“Experimental Procedures” andWestern-blotted with the indicated antibod-
ies. C, quantification of translocator secretion after CR induction. Samples
from two independent experiments, one of them performed in duplicate,
were quantified onWestern blottings. The averages and standard deviations
of the wild-type normalized data are displayed. There is an overall difference
between proteins and strains in an ANOVA (p 0.01 and p 0.001, respec-
tively). In pairwise comparisons, the difference betweenmxiC and both the
complemented strain and mxiCNterm is statistically significant (post hoc
test with Bonferroni correction, p  0.001 and p  0.01, respectively),
although the difference between complemented strain and mxiCNterm is
not significant.
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early effector IpgD were secreted at intermediate levels of
40–50%. Thus, either only a small proportion of intracellular
MxiC is involved in blocking secretion and/or its secretion per
se is not required to release this block.
Any MxiC Chaperone Remains Unidentified—As MxiC’s
putative CBD is essential for regulating the protein’s secretion
and asYersiniaYopNneeds its heterodimeric chaperone SycN/
YscB for efficient secretion and regulation (25, 30), we won-
dered whether a chaperone is required for MxiC function.
Three chaperones are encoded on the pWR100 virulence plas-
mid of Shigella that fall into the same general class as SycN and
YscB: IpgA, IpgE, and Spa15 (31). Botteaux et al. (23) already
found the lack of any of these proteins alone has no effect on
MxiC secretion or stability. Thus, none of the Shigella class I
chaperones work like SycN/YscB. However, their mechanism
of action could be different, and thus we generated two double
deletions (ipgEspa15 and ipgEipgA) and a triple deletion






































































































FIGURE3.Putative chaperone-bindingdomain regulatesMxiC secretionand is required forblockingeffector secretion.A,protein secretion in response
to the artificial inducer CR. Samples from the complemented strain (mxiC/mxiC) and indicatedmxiCmutants (in themxiC background) were collected as
described under “Experimental Procedures,” silver-stained (top panel), and Western-blotted with the indicated antibodies (bottom panels). B, exponential
leakage. Samples were collected as described under “Experimental Procedures,” silver-stained (top panel), andWestern-blotted with the indicated antibodies
(bottompanels).C, total protein expression levels inwhole culture lysates. Sampleswere collected as describedunder “Experimental Procedures” andWestern-
blotted with the indicated antibodies. Results shown are representative of at least two independent experiments.
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chaperones had no effect onMxiC (supplemental Fig. S7). This
suggests that none of these chaperones influences MxiC func-
tion. Therefore, either there are no such chaperones binding to
theCBDofMxiC, orwehave not identified thembecause of low
sequence similarities. However, we think the latter is unlikely
because MxiC is primarily monomeric in cytosol, and no
known class 1 chaperone was identified, even using mass spec-
trometry after cross-linking (32).
Hydrophobic Patch on the Surface of MxiC Is Required for
Blocking Effector Secretion—Deane et al. (21) noticed conserva-
tion of a patch of hydrophobic residues on the surface ofMxiC’s
domain 2 (Fig. 1, bottom; Leu-222, Met-226, Gly-239, Leu-242,
and Leu-245), suggesting it as a site for protein-protein inter-
actions. Cherradi et al. (33) changed single residues in this
patch to alanines. MxiC is not detectable in mxiCL222A and
mxiCL242A, although three other mutations (M226A, G239A,
and L245A) do not effect its function. We mutated residues
Leu-222 and Leu-242 into serines and found that neither
mxiCL222S and mxiCL242S nor the double mutant mxiC
(L222S,L242S) had any effect on MxiC stability or function
(data not shown).
As change to a polar side chainmay not have been enough to
disrupt interactions in this area, we introduced two charges.
The mxiC(M226K,L242D) mutant was stably expressed (Fig.
4C) and able to induce translocator secretion after induction
(Fig. 4A). However, mxiC(M226K,L242D) was unable to pre-
vent effector secretion (Fig. 4, A and B). Thus, the hydrophobic
patch is involved in preventing effector secretion.
Mutations in a Putative “Hinge”Area ofMxiCLead toAltered
Secretion Patterns—The sequence in MxiC helix 9, its putative
“hinge” region (Fig. 1, top), is not conserved. However, it con-
tains multiple serines, aspartates, valines, and threonines that
arenot classically helix favoring (34).Multiple secondary structure
prediction programs suggest that even in MxiC, helix 9 would be
broken (supplemental Fig. S8B). We generated a model of the
“bent” wild-type protein using the YopN/TyeA structure (PDB
code 1XL3 (20)) as template (supplemental Fig. S8A). In compar-
ison with the crystal structure, the bentMxiCmodel is not only
folded at the hinge region but undergoes a slight twisting
motion. We then made three mutants as follows: one mutant
introducing a proline (V256P; bent) that would likely cause a
break in helix 9 and thus a conformation similar to that of
YopN/TyeA; a second mutant introducing three glycines
(T253G, S254G, and D255G; “wobble”) in the area to favor
switching between both putative forms; and a thirdmutant that
might stabilize a straight helix (I251A, T253A, S254A, and
D255E; “straight”). MxiC Ile-251 is structurally equivalent to
Phe-268 of YopN, which is sandwiched between hydrophobic
residues in the core of TyeA, thus likely stabilizing the bent
conformation.
All mutant proteins were expressed at wild-type levels
or better (Fig. 5C). The triple glycine mutant mxiC(T253G,
S254G,D255G) behaved like mxiC. MxiC was not secreted
efficiently, and translocator secretionwas reduced (43 23%of
the complemented strain), and effector proteins were leaked.
Under the straight mutantmxiC(I251A,T253A,S254A,D255E),
induced secretion of both IpaB and IpaC was reduced, whereas
that of IpaD was as efficient as in the complemented strain or
even increased (Fig. 5D). Thismutant did not affect secretion of
MxiC or effector proteins. The bentmutantmxiCV256P leaked
high levels of a lowmolecular weight protein.We identified this
band by mass spectrometry using a sample equivalent to the
“CR” sample in Fig. 5A. The top T3S-related protein identi-
fied was effector IpgB1 (6% of the total protein content). The
similarly sized effector/anti-activator OspD1 was not detected
in this band. The equivalent band from amxiC “CR” sample
was analyzed in parallel; again, IpgB1 was the top T3S-related
hit (32). ThemxiCV256Pmutant also leakedMxiC at wild-type
levels and other effector proteins, although less thanmxiC. Its
own inducible secretion was reduced and that of all transloca-
tors slightly affected (Fig. 5D). These results suggest that a
“straightened” MxiC favors the earliest step in the induction
hierarchy, i.e. IpaD secretion, whereas a bentMxiC cannot pre-
vent or favors, independently of its own secretion, the final one,
i.e. effector release. In the wobbly mutant, three residues are
altered that are initially identical to those changed in the
straight one, but its phenotype is opposite, i.e. more like the
bent one. This indicates that it is not the chemical nature of
the amino acids in this surface patch that leads to these pheno-
types but rather the stability of the secondary structure they
form.
MxiC Is Not in Its Straight Conformation in Solution—The
secretion patterns observed in the helix 9 mutants suggested
movement in this area of MxiC is required for its function. We
decided to examine the molecular conformation(s) of MxiC
using double electron-electron resonance (DEER), also known
as pulsed electron double resonance (PELDOR). This is an
increasingly popular electron paramagnetic resonance (EPR)
technique used to measure distances between paramagnetic
spin labels on a nanometer scale (52).
Based on the MxiC structure (chain A of PDB entry 2VJ4
(21)) and the bent model (supplemental Fig. S8A), we chose
residues Ala-247 and Ser-290 to introduce paramagnetic cen-
ters into the molecule as the distance between these residues
was predicted to be in themeasurable range for both forms, and
the difference in distance between both forms was predicted as
significant enough to be detectable (supplemental Fig. S9). To
covalently couple the paramagnetic nitroxide label MTSL to
these residues, Ala-247 and Ser-290 were mutated into cys-
teines. At the same time, the two endogenous cysteinesCys-184
andCys-233weremutated into alanine and serine, respectively,
to finally generate a quadruple mutant mxiC(C184A,C233S,
A247C,S290C) or mxiC(Cys). Alternatively, complementary
mutantMxiCs, with cysteines for labeling inserted at two sets of
different but equally suitable locations, could not be purified in
sufficient amounts (data not shown).
The mxiC(Cys) behaved like the complemented strain in a
CR secretion assay (supplemental Fig. S10). A His-tagged ver-
sion of the cysteine mutant (His-MxiC(Cys)) was soluble when
expressed in E. coli (supplemental Fig. S11A). We also com-
bined the quadruple cysteine mutant with the previously gen-
erated bent (mxiCV256P) and straight (mxiC(I251A,T253A,
S254A,D255E)) mutants. However, neither His-MxiC(bent,
Cys) nor His-MxiC(straight,Cys) were solubly expressed in
E. coli (data not shown). Thus, we could only analyze the “wild-
type” His-MxiC(Cys).
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MTSL was covalently coupled to His-MxiC(Cys) at residues
247 and 290. The protein was concentrated and mixed with
deuterated glycerol for EPR/DEER experiments (for details see
under “Experimental Procedures”). The labeling efficiency was
assessed using continuous wave room temperature EPR on a 35
M sample (Fig. 6A). Using a previously obtained standard
curve, the spin concentration was calculated to be 66 M. The
amount of residual unbound label was calculated to1%; thus
a spin labeling efficiency of close to 100% could be extracted.
The spectrum also indicated the protein was folded; because of
increased mobility in a disordered structure, an unfolded pro-
tein would result in a spectrum similar to that of the free label.
We subsequently performed a DEER experiment to deter-
mine the distance distribution of the paramagnetic labels on
Cys-247 and Cys-290. We obtained a distance distribution
between 1.5 and 3 nm with two prominent peaks at 2 and 2.4
nm (Fig. 6,B andC). Reliability of the two peaks comes from the
high signal-to-noise F(t) trace. We simulated the expected dis-
tance distribution for the bent MxiC model (Fig. 6C) and the




























































































FIGURE 4. Conserved hydrophobic patch on the surface of MxiC is involved in preventing effector secretion. A, protein secretion in response to the
artificial inducer CR. Shigellawild type,mxiCmutant, complemented strain (mxiC/mxiC), andmxiC(M226K,L242D) (in themxiC background) were grown
with 25 M IPTG where required. Samples were collected as described under “Experimental Procedures,” silver-stained (top panel), and Western-blotted with
the indicated antibodies (bottom panels). B, exponential leakage. Samples were collected as described under “Experimental Procedures,” silver-stained (top
panel), and Western-blotted with the indicated antibodies (bottom panels). C, total protein expression levels in whole culture lysates. Samples were collected
as described under “Experimental Procedures” andWestern-blotted with the indicated antibodies. Results shown are representative of at least two indepen-
dent experiments.
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FIGURE 5. Mutants designed to alter the conformation of MxiC show opposed phenotypes. A, protein secretion in response to the artificial inducer CR.
Shigella wild type, mxiC mutant, complemented strain (mxiC/mxiC), and mxiC mutants (in the mxiC background) were grown with 25 M IPTG where
required. Mutant mxiC(T253G,S254G,D255G) is abbreviated mxiC(wobble) and mutant mxiC(I251A,T253A,S254A,D255E) is abbreviated mxiC(straight). Samples
were collected as described under “Experimental Procedures,” silver-stained (top panel), andWestern-blottedwith the indicated antibodies (bottompanels). B,
exponential leakage. Sampleswere collected as describedunder “Experimental Procedures,” silver-stained (top panel), andWestern-blottedwith the indicated
antibodies (bottom panels). C, total protein expression levels in whole culture lysates. Samples were collected as described under “Experimental Procedures”
and Western-blotted with the indicated antibodies. D, quantification of translocator secretion after CR induction. Samples from three independent experi-
ments were quantified on Western blottings and normalized against the complemented strain mxiC/mxiC. The averages and standard deviations are
displayed. There is an overall difference between proteins and strains in an ANOVA (p 0.01 and p 0.001, respectively). In pairwise comparisons (post hoc
testwith Bonferroni correction), the difference betweenmxiC(T253G,S254G,D255G) andmxiC/mxiC is statistically significant (p 0.001), and the same
is true for mutant mxiCV256P. Both strains are not significantly different from the mxiC mutant. Mutant mxiC(I251A,T253A,S254A,D255E) is overall
significantly different from mxiC (p  0.001), but not from the complemented strain. There are also significant differences between proteins in the
mxiC(I251A,T253A,S254A,D255E) mutant (p  0.01 in an ANOVA). Specifically, IpaD is significantly different from both IpaB and IpaC (post hoc test with
Bonferroni correction, p 0.05 and p 0.01, respectively).
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(35) and found the experimental data obtained for labeled His-
MxiC(Cys) fit neither simulation well (Fig. 6). The major dis-
tance peak for the straight MxiC structure was around 3 nm,
and under the bentMxiCmodel, themajor expected distance is
at 1 nm. As the distance simulations depend on the orienta-
tion of the side chains to calculate the probabilities of the label
rotamers, we simulated the expected form factors and distances
for all seven individual chains in the three MxiC crystal struc-
tures (PDB codes 2VIX, 2VJ4, and 2VJ5 (21)) (supplemental Fig.
S12). Although themodeled form factors all differ in their over-
all shapes, they all show distances in the 1.5–3-nm range, in line
with the experimental setup. However, the simulated peak at 3
nm was not as prominent in the experimental data. We thus
conclude that the experimental data are not consistent with the
structures nor with the bent model. When modeling the possi-
ble observable distances in the structure and the bent model
using the “all rotamers” function inMMM (35), which neglects
side-chain atoms, labeling of the chosen sites in both confor-
mations can achieve a distribution close to the experimentally
observed distribution (data not shown). Thus, the conforma-
tion(s) of purifiedMxiC in solution is consistent with both bent
and straight forms.
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FIGURE 6.His-MxiC(Cys) is nearly completely labeled withMTSL and the 247–290 interspin distance distribution is between that of the straight and
bent forms. His-MxiC(Cys) was modified with MTSL as described under “Experimental Procedures.” The labeling efficiency was assessed using room temper-
ature continuous wave EPR. The resulting EPR derivative signal is displayed in arbitrary units (a.u.). A, labeling efficiency in His-MxiC(Cys) alone. The spin
concentration is 66M, and100% of His-MxiC(Cys) was modified by MTSL (the residual free label fraction is marked with an asterisk). B and C, left column,
V(t)/V(0) is the primary DEER data; the inset in B shows the background-corrected F(t)/F(0) with the fit (red dotted line). In the right column, P(r) indicates the
probability for thedifferent distances extractedwithmodel-free Tikhonov regularizationusingDeerAnalysis. The red dotted lines show the simulationbyMMM.
B, comparison of the bentMxiCmodel with the experimental data for His-MxiC(Cys). C, comparison of theMxiC crystal structure (PDB code 2VJ4, chain A) with
the experimental data for His-MxiC(Cys). Comparisons with all other chains in all crystal structures are shown in supplemental Fig. S12. The chain presented in
this panel was chosen because it was used as template to model the bent form of MxiC.
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IpaD Interacts with MxiC in Solution without Altering Its
Conformation—As EPR only detects signals fromparamagnetic
centers, one can add potential binding partners to the sample
without affecting the signal as long as they are diamagnetic.
To determine whether other T3S-related proteins influence
MxiC’s conformation, we mixed labeled His-MxiC(Cys) with a
10-fold molar excess of the proposed interaction partner IpaD
(15) or Spa15 (supplemental Fig. S11B), a protein that is not
known to interact with MxiC (23). Spa15 addition did not
change the continuouswave EPR spectrum (Fig. 7A), indicating
Spa15 does not influence the rotational freedom of the labels in
MxiC. Consistently, the DEER form factor and resulting dis-
tance distributionwere also unchanged (data not shown). Thus,
Spa15 does not affect MxiC’s conformation in vitro.
In contrast, addition of a 10-fold molar excess of purified
His-IpaD (supplemental Fig. S11C) changed the continuous
wave (cw) spectrum obtained (Fig. 7C), indicating the confor-
mational freedom of the spin-labeled side chains has been
affected by IpaD-MxiC complex formation, either due to direct
interaction with IpaD residues or to subsequent conforma-
tional changes in MxiC. To confirm IpaD was responsible for
signal modification, we mixed MxiC with different concentra-
tions of IpaD (Fig. 8D). We found that the larger the stoichio-
metric fold of IpaD versus MxiC, the bigger was the spectral
change detected. This shows the signal modification is specific
to IpaD addition and that, in the concentration range used, we
can modify the ratio of the MxiC-IpaD complex versus MxiC
alone in the equilibrium ensemble. We also diluted the 10:1
IpaD/MxiCmix 1:4 (Fig. 7E). This confirmed that in preventing
the interaction between MxiC and IpaD by dilution, the MxiC
alone signal is recovered, meaning the interaction is reversible.
Given the evidence that MxiC family proteins can interact
directlywith translocator chaperones (27, 36–38), we also puri-
fied the IpgC dimer and an IpaC-IpgC 1:1 heterocomplex
(supplemental Fig. S11D) (39). Neither of these, added at
10-fold molar excesses, interacted withMxiC alone (Fig. 7B) or
when added in the presence of a 10-fold molar excess of IpaD
(Fig. 7C). Taken together, these data indicate that in solution
only IpaD displays an affinity for MxiC. However, we found no
evidence of a distance change between the two spin-labeled side
chains byDEERupon addition of any protein partners (data not
shown).
mxiC Mutants Unable to Prevent Effector Secretion Are
Affected Differentially by Needle Mutant mxiHK69A, Which Is
Unable to Release MxiC and Hence Effectors—To dissect at
which point they are deregulated, we wanted to understand
whether our mxiC mutants that leak effectors do so because
MxiC’s function(s) in blocking effector secretion is compro-
mised or because they cannot retain MxiC intracellularly. We
examined this by combining them with a mutation that pre-
vents MxiC secretion,mxiHK69A.
AnmxiHK69Amutant in the needle protein does not secrete
effector proteins (16) nor MxiC (12). However, an mxiHK69A
mutant lacking MxiC (mxiHmxiC/mxiHK69A) can secrete
effectors (12). Thus,mxiHK69A does not physically block effec-
tor secretion, but it is unable to releaseMxiC’s block of effector
secretion.
When combining ourmxiCmutants withmxiHK69A, MxiC
mutants that cannot prevent secretion because themutation(s)
is affecting function should continue to leak effectors even if
MxiC is retained inside bacteria. For instance, the hydrophobic
coremxiCF206Smutant (Fig. 1) analyzed byCherradi et al. (33)
is not secreted in an mxiHK69A background but is still unable
to block effector secretion. This indicates it has a severe defect
in its inhibitory function that is independent ofMxiC secretion.
However, mutants where MxiC is functional but is secreted
prematurely should prevent effector secretion when MxiC is
forced to remain intracellular. To test this, we generatedmxiH
and mxiHK69A plasmids compatible with our mxiC mutant
ones, which were then co-transformed into mxiCmxiH (see
under “Experimental Procedures”).We focused solely onMxiC
mutants displaying premature secretion of effectors and MxiC
leakage. For completeness, we also included mxiC(E201K,
E276K,E293K), which carriesmutations in a negatively charged
surface patch (Fig. 1, top), secretes translocators andMxiC pre-
maturely, and is defective in IpaD secretion upon activation
(15).
We were unable to detect leakage from mxiCmxiH/
mxiCmxiH (data not shown), and its inducible secretion was
also slightly reduced compared with wild type but of a similar
level to that ofmxiCmxiH/mxiCmxiHK69A (Fig. 8, top pan-
els). Indeed, slightly fewer functionally mature T3SSs are
assembled in mxiH/mxiHK69A relative to wild type (16).
However, as expected, mxiCmxiH/mxiCmxiHK69A could
not leak or induce secretion of the effectors IpaA or IpgD nor of
MxiC (Fig. 8, bottom panels), respectively. However, it secreted
slightly reduced amounts of the translocators inducibly, as
observed previously (16). In mxiCmxiH/mxiHK69A, IpaA
and IpgD leakage was restored, and their secretion was also
partially inducible (Fig. 8, bottom panel). We then examined
how eachmxiCmutant behaved in anmxiHK69A background.
We focused on leakage in the absence of induction because
activation of MxiC secretion is blocked in anmxiHK69A back-
ground but effector secretion might be allowed by a function-
ally defective MxiC.
OnlymxiCK68E was unable to leak or induce effector secre-
tion in the presence of mxiHK69A but not of mxiH. This indi-
cates it is the only mutant where MxiC would be functional in
blocking effector secretion, if it were not secreted prematurely.
All other mutants leak effectors similarly whether mxiH or
mxiHK69A is present, indicating that in these mutants MxiC’s
function(s) in blocking effector secretion are affected, either
directly as inmxiC(M226K,L242D) or indirectly, via premature
secretion of translocators as inmxiC(E201K,E276K, E293K).
Discussion
Classes of mxiC Mutants—Our mutants can be organized
into classes according to their phenotypes (Table 1). However,
residues mutated in the different classes do not obviously clus-
ter in specific regions of the molecule (Fig. 1). Moreover, none
seems affected only in a single step, i.e. regulation of transloca-
tor, MxiC, or effector secretion. This indicates the three
regulatory functions of MxiC are interlinked. Therefore, the
mutants were classified according to where their main initial
defect lies, assuming the regulatory steps occur in this order.
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Only one mutant showed such severe loss-of-function as to
resemble mxiC, mxiCCterm, which we therefore placed in
class 0. However, unlike mxiCCterm, mxiCNterm and
mxiCCBD were still largely able to induce translocator, but
not MxiC, secretion, suggesting they are not full loss-of-func-
tion mutants (class 1a). Mutant mxiCV256P also could not
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secreteMxiCwell inducibly or in aipaB background, suggest-
ing it has some defect in MxiC secretion. This mutant leaks
effectors, but as it can still stimulate secretion of translocators,
it is also not a complete loss-of-functionmutant (class 1a). Both
classes ofmutants readily by-passed the block on effector secre-
tion imposed bymxiHK69A, although none secretedMxiC effi-
ciently in this background, indicating they are unable to estab-
lish all or some of MxiC’s regulatory functions.
mxiCK66E andmxiCK68E are phenotypically similar in that
they secreteMxiC prematurely and hence show reduced trans-
locator induction and increased effector leakage. However,
MxiCK68E is secreted much more efficiently than MxiCK66E.
Furthermore, among allmutants, onlyMxiCK68E does not leak
effectors in anmxiHK69A background. This indicates that the
mutations inMxiCK68E andMxiCK66E, despite their proxim-
ity and chemical similarity, lead to different defects. K68E (class
1c) primarily deregulates MxiC secretion, leading it and effec-
tors to be secreted prematurely. In addition to some premature
secretion, K66E (class 1b) seems to confer more fundamental
defect(s) leading to effector leakage. Finally, the only defect
seen inmxiC(M226K,L242D) is effector leakage (class 1d).
Class 2mutants are primarily, if oppositely, affected in trans-
locator release. MxiC(E201K,E276K,E293K) cannot induce
IpaD secretion but leaks IpaB, IpaC, itself, and effectors (15),
although MxiC (I251A,T253A,S254A,D255E) displays in-
creased IpaD secretion and reduced IpaB and IpaC secretion.
Properties of MxiC and Roles of Its Termini—Using the
mutant classes, we conclude that several physiological features
of MxiC are regulated as follows: 1) its secretion, because sev-
eral mutants up- or down-regulate it; 2) hierarchical secretion
of translocators and effectors, and even of proteins within those
two categories; and 3) the ability to switch from translocator to
effector secretion. There are also uncharacterized fundamental
properties of MxiC as indicated by mutations that most likely
do not affect its overall structure, i.e. mxiCCterm and
mxiCNterm, but still lead to full or partial null phenotypes,
respectively.
MxiC’s secretion signal and putative CBD are dispensable for
stimulation of translocator secretion, which indicate domains
1–3 alonemediate this function.Multiple residues in the C-ter-
minal helix of MxiC are highly conserved. Schubot et al. (20)
suggested that the C-terminal helix of Yersinia TyeA (a MxiC
FIGURE 7.Continuouswave EPRdetects aweakbut specific interaction ofMxiCwith IpaD.A, cw EPR spectrumof spin-labeledMxiC in the absence (black)
and in the presence of 10-fold excess of Spa15 (cyan). B, cw EPR spectrum of spin-labeled MxiC in the absence (black) and in the presence of 10-fold excess of
IpgC (red) or IpgC-IpaC (orange). C, left, cw EPR spectrum of spin-labeled MxiC in the absence (black) and in the presence of 10-fold excess of IpaD (green) or
IpaD-IpagC-IpaC (red). Right, themagnified low field region of the spectra (331.5–334.5mT) highlights the detectable spectral differences.D, cw EPR spectrum
of spin-labeled MxiC in the absence (black) and in the presence of n-fold excess of IpaD (indicated in legend). E, cw EPR spectrum of spin-labeled MxiC in the
absence (black) and in the presence of 10-fold excess of IpaD (green) and after 1:4 dilution (olive green). The inset shows the magnified low field region of the
spectra (331.5–334.5 mT), which highlights the fact that upon dilution the spectrum reverts to that of MxiC alone (except for a small fraction of free label, see
asterisks), indicating that complex formation can be detected only at high protein concentrations due to the low affinity. The normalization of the spectral
intensity of the diluted sample was done where indicated by the arrow to remove the effect of the free label. Except where otherwise stated, the spectra are
normalized to the maximum amplitude of the central EPR line. The insets show the magnified low field region of the spectra (331.5–334.5 mT) to highlight
possible spectral differences. The asterisks highlight the minor fraction of label, which is released during the incubation with some protein complexes and/or
upon dilution.
FIGURE 8. Analysis ofmxiCmutant phenotypes in themxiHK69A background. Protein secretion in response to the artificial inducer CR is shown. Shigella
wild type, mxiCmxiH mutant, complemented strains (mxiCmxiH/mxiCmxiH or mxiCmxiH/mxiCmxiHK69A), and mxiC mutants (in the mxiCmxiH
background expressing eithermxiH ormxiHK69A) were grownwith 25M IPTGwhere required.MutantsmxiC(E201K,E276K,E293K) andmxiC(M226K,L242D) are
abbreviated mxiC(negative) and mxiC(hydrophobic), respectively. Samples were collected as described under “Experimental Procedures,” silver-stained (top
panel), and Western-blotted with the indicated antibodies (bottom panels). Arrow indicates faster migration ofMxiCCBD.
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domain 3 homolog that binds the C terminus of YopN, a MxiC
domains 1–2 homolog) might localize the YopN-TyeA com-
plex to the secretion apparatus. Ferracci et al. (19) found TyeA
to be essential for YopN to block secretion. In addition, several
mutants in the hydrophobic core of domain 2 (Fig. 1) of MxiC
are non-functional or at least unable to block secretion (33). In
contrast, equivalent mutations in Yersinia yopN lead to a gen-
eral block of secretion (19, 33). However, the yopN mutants
analyzed by Ferracci et al. (19) were overexpressed in compar-
ison with wild-type levels. In our hands, overexpression of the
non-functional hydrophobic core of domain 2 mxiCD225V
mutant (Fig. 1) also led to a general block of secretion (data not
shown). This suggests MxiC blocks an acceptor site on the
secretion apparatus, and toomuch non-removable protein pre-
vents release of this repressor, consequently blocking secretion.
In support of this, Lee et al. (40) showed Pcr1, the Pseudomonas
T3SS homologs ofYersiniaTyeA, interacts with the T3SS inner
membrane protein PcrD, known as MxiA in Shigella. Further-
more, the extreme C terminus of MxiC is required for interac-
tion with the cytoplasmic region of MxiA (41), explaining the
null phenotype ofmxiCCterm. As mutants in the N terminus
and CBD are unable to secreteMxiC inducibly and anN-termi-
nal His tag on MxiC led to a mxiC phenotype (data not
shown), these regions may also be involved in binding it to and
releasing it from that site.
MxiC Differentially Affects Secretion of IpaD and Hydropho-
bic Translocators—Translocator secretion was largely unaf-
fected in class 1a and 1dmutants, although all had clear defects
in blocking effector secretion. In contrast, mutants from class 2
modulated translocator secretion, but effector secretion was
affected indirectly (mxiC(E201K,E276K,E293K)) or not at all
(mxiC(I251A,T253A,S254A,D255E)). Thus, the action ofMxiC
on translocators and effectors can be uncoupled. MxiC
(E201K,E276K,E293K) acts as if it had already received the acti-
vation signal (15). Thus,MxiC’s action on translocators can also
be uncoupled from the needle-transmitted activation signal. In
addition, MxiC secretion is not required for activating translo-
cator secretion, as an mxiHK69A mutant, which does not
secrete MxiC, andmxiCNterm secrete normal levels of trans-
locators (12, 16).
Even hydrophilic versus hydrophobic translocator secretion
can be uncoupled because mxiC(E201K,E276K,E293K) leaks
IpaB and IpaC and is unable to induce IpaD secretion (Roehrich
et al. (15)). Interestingly, the straight mutant mxiC(I251A,
T253A,S254A,D255E) instead displays reduced induction of
IpaB and IpaC, although IpaD secretion is slightly increased.
These opposite effects correlate with the mutations being on
opposite faces of MxiC (Fig. 1, top). These faces are also the
ones that may undergo a conformational change from flat to
bent (21). In fact, this is the conformational change we tried to
TABLE 1
Phenotypic overview of mutants
NA means not applicable, and ND means not determined.
a This indicares poorly detected in whole cell lysate.
b This indicares that IpaB/C increased.
c This indicares not IpaD.
d IpaC/B was reduced, IpaD slightly increased.
e IpgB1 was increased.
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prevent in mxiC(I251A,T253A,S254A,D255E). Furthermore,
the predicted bent mutant (mxiCV256P) and the predicted
straight mutant show opposite phenotypes; although the for-
mer leaks effectors and is only weakly affected in translocator
secretion, the latter shows differential induction of transloca-
tors. Thus, reduced secretion of the repressor IpaD could affect
secretion of the hydrophobic translocators. Alternatively or
additionally, MxiCV256P was only poorly secretable and could
be affected in more fundamental functions. Although we can-
not exclude that these mutations mainly affect MxiC interac-
tions by altering its surface, the type of mutations, the fact that
the mutations are directly adjacent, and their opposite pheno-
types suggest that we have modified MxiC’s ability to undergo
conformational changes.
Conformational Change in MxiC?—The negatively charged
patchmutated inmxiC(E201K,E276K,E293K) lies on the face of
the molecule that is flat in MxiC but concave in YopN/TyeA
and the E. coli homolog SepL (26). As the straight mutant
favored IpaD secretion, a flat negatively charged patchmight be
required for this. Lower levels of IpaB and IpaC secretion could
then be due to the restricted conformation or to the mutations
themselves. In other words, IpaB and IpaC secretion could
require either a bent conformation or the area in helix 9 that
was mutated in mxiC(I251A,T253A,S254A,D255E), or both.
The latter is supported by the work of Archuleta and Spiller
(27), which indicates that a flattened gatekeeper structure has a
conserved binding site for translocator chaperones, such as
IpgC in Shigella, at this location. In the Salmonella SPI-1 sys-
tem, the MxiC homolog InvE interacts with complexes of
hydrophobic translocators and their chaperone (36). An inter-
action betweenMxiC or its homolog and the class 2 chaperone
IpgC or its homolog has also been shown in Shigella and
Chlamydia (33, 38). Finally, we identified substoichiometric
amounts of IpgC and all translocators in our interaction partner
screen (32).
MxiC Directly Interacts with IpaD—Unfortunately, we were
to unable to test for any conformational change in MxiC by
EPR. However, we did detect an interaction betweenMxiC and
IpaD via this method. The spectral changes observed in the
continuous wave EPR experiments whereMxiC(Cys) and IpaD
were mixed have two possible explanations as follows: (i) the
increased molecular weight of the complex(es), which is
reflected in slower overall rotational correlation times; (ii) a
direct interaction between the spin-labeled probes and residues
in IpaD. Although the reason of the spectral effects observed
cannot be clarified, it corroborates the notion that complex
formation between MxiC and IpaD occurs. From Fig. 7B,
assuming the 1:10 MxiC/IpaD concentration corresponds to
themaximumamount of complex formation and therefore that
a 1:5molar ratio IpaD gives half-maximumcomplex concentra-
tion, we estimate the dissociation constant of the MxiC-IpaD
complex is730 M, i.e. these purified proteins have very low
affinity. This suggests we have not fully reconstituted interac-
tions between these proteins in vitro. We may be lacking their
“scaffold.” Does the MxiAC oligomer, aided by other T3SS
export apparatus components, perhaps stabilize one of MxiC’s
conformations?
Based on the crystal structures of IpaD (42) and MxiC (21)
and themutations genetically affecting the interaction between
these proteins (ipaDL99P and mxiC(E201K,E276K,E293K)
(15)), we built a model of theMxiC-IpaD interaction; theMxiC
and IpaD structures pack readily against each other (Fig. 9A),
with the negatively charged patch of MxiC (Glu-201, Glu-276,
and Glu-293) at their interface, yielding an overall elongated
form. The interacting surface is relatively flat and contains sev-
eral charged residues on the edges and stacked tyrosine resi-
dues in the center giving an interface formed by two charge-
complementary surfaces (Fig. 9B). This model is consistent





FIGURE 9.ModelingofMxiC-IpaD interaction.A,docking of grayMxiC (PDB
entry 2VJ4 chain A (residues 64–349) (21), pink) and colored IpaD (PDB entry
2J0O chain A (42)). The N-terminal domain of IpaD is colored in blue (residues
40–130); the C-terminal globular domain is colored in red (residues 177–271);
and the coiled-coil domain is colored in green (residues 131–176 and 272–
321). Residues Glu-201, Glu-276, and Glu-293 involved in the negatively
charged patch of MxiC are highlighted as space-fill model. The bottom panel
is rotated 90° around the x axis compared with the top panel illustrating the
elongated shape of the dimer. B, interface of the MxiC IpaD dimer shows
complementary charges. The top panel shows the electrostatic potential sur-
face of IpaD and the backbone of MxiC, and the bottom panel shows the
electrostatic potential surface of MxiC and the backbone of IpaD. The panels
are rotated 180° with respect to each other. Negative charges are shown in
red and positive charges are depicted in blue. The docking was performed
manually using the location of ipaD and mxiC mutants. The model was gen-
erated in Insight II 2005 and optimized using Discover 2.98. Electrostatic
potential surfaces were calculated using Delphi (all Accelrys Inc.).
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PcrG, a homolog of theN terminus of IpaD, interacts with Pcr1,
a MxiC domain 3 homolog. Taken together with the work of
Archuleta and Spiller (27), our model suggests why MxiC’s N
terminus and CBD are dispensable for stimulating translocator
secretion.
Intramolecular and External Signals for MxiC Secretion—By
analyzing themxiCNtermmutation in the constitutive secre-
tor background ipaB, we confirmed that this mutant is
unsecretable. Similar to the N-terminal secretion signal, the
putative chaperone-binding domain is required for efficient
MxiC secretion.However, this domain did not affect secretabil-
ity. Thus, MxiC secretion is merely deregulated inmxiCCBD.
Interestingly, two different mutations in the CBD of MxiC led
to increased MxiC leakage, mxiCK68E and mxiCK66E. Taken
together, these data suggest that the putative chaperone-bind-
ing domain positively regulates MxiC secretion.
The chaperone-binding domain is irrelevant forMxiC secre-
tion in theipaB background. This is reminiscent of the lack of
requirement of MxiC for translocator secretion in the same
background. Similar to the repression of translocator secretion
(12), an intracellular repressor mechanism for MxiC secretion
might be put into place once the tip is fully assembled; the CBD
would be involved in counteracting this mechanism, and
mutantsmxiCK68E andmxiCK66Ewould then either be better
at counteracting the mechanism repressing MxiC secretion or
less sensitive to it.
The “external” signal for MxiC secretion has not yet been
identified.However, this signal is likely transmitted through the
needle as anmxiHK69Amutant is unable to release MxiC even
when secretion is artificially activated by additional deletion of
ipaB (12). The question of howmxiHK69A blocks MxiC secre-
tion remains; the mxiHK69A mutant is either unable to trans-
mit an external activation signal for MxiC secretion generated
after the translocators have been secreted or this mutation
alters the affinity of the secretion apparatus for MxiC (12, 32).
Mutants mxiCK68E and mxiCK66E leaked the respective
mutant protein and hence probably overcame an intracellular
repression mechanism for MxiC secretion. Similarly, mxiC
(E201K,E276K,E293K) has gained the ability to activate its own
secretion (15). However, none of these mutants is inducibly
secreted in the mxiHK69A background. Indeed, we did not
identify any mutation allowing induction of MxiC secretion in
themxiHK69A background. Thus, in addition to blocked trans-
mission of Signal 2, the secretion apparatus in the mxiHK69A
mutant was unable to release/recognize MxiC as a secretion
substrate.
MxiC Secretion per se Is Not Required to Derepress Effector
Secretion—In the wild type, the needle transmits the activation
signal to MxiC, whose subsequent secretion leads to derepres-
sion of effector secretion. Class 1a mutants, which only secrete
MxiC poorly but leak effectors, show that effector secretion and
MxiC secretion can also be uncoupled. In other words, MxiC
secretion per se is not required for allowing effector secretion.
Not all MxiC homologs are secreted (28). However, the gate-
keepers must be removed from their initial place of action; in
the Salmonella SPI-2 system where the MxiC homolog SsaL is
not secreted, the protein dissociates from the membrane and is
degraded once secretion is activated (43).
Are There Further Regulatory Function(s) for MxiC?—
MutantmxiCV256P leaked effectors, including very high levels
of IpgB1. IpgB1 is an effector protein chaperoned by Spa15 (24,
44). The specific effect of mxiCV256P on IpgB1 suggests that
MxiC somehow directly affects secretion of at least some effec-
tors. Similarly, E. coli SepL was shown to specifically act on the
effector Tir. This protein-protein interaction was proposed to
be critical for regulating secretion of the other effector proteins
(28). Although this does not exclude a possible effect of MxiC
on effector secretion in a more general way, e.g. by modulating
the affinity or physically blocking an acceptor site for effectors
in the T3SS, it suggests that secretion of specific effectors
involves an additional regulatory layer.
Steps in MxiC Function—After T3SS assembly, but before
secretion activation,multiplemechanisms are in place that pre-
vent premature secretion of the different protein types. Trans-
locator secretion is repressed by IpaD, probably via interaction
with MxiC bound to MxiA. An uncharacterized mechanism
prevents MxiC secretion, although this protein itself prevents
effector secretion.When the needle tip comes in contact with a
host cell, an activation signal (“Signal 1”) is transmitted to the
cytoplasm, most likely through the needle.
The mechanism preventing premature translocator secre-
tion is counteracted by MxiC. Secretion of IpaD requires the
negatively charged patch and probably a flat conformation of
the molecule. Removal of IpaD may initiate a conformational
change in MxiC, which bends to release the IpgC chaperone
and its bound translocators allowing these to become secreted
in turn. IpaB and secreted IpaC form a pore, connected to IpaD
at the needle tip and also inserted in the host cell membrane,
which transmits “Signal 2” to the cytoplasm. Reception of this
signal may allow finalization of a conformational change in
MxiC that releases it for secretion. Then, early effectors are
secreted. Moreover, as both negative regulators are now
removed, the secretion rate is enhanced (40), possibly through
alteration of its mode (41).
By using structure- and sequence-based mutagenesis of
mxiC, we dissected at which stages of the regulatory cascade
MxiC acts, includingwhich of its functional steps can be uncou-
pled. This also allowed us to determine how the different steps
are connected. Finally, we provide the first evidence that a
directionally defined conformational change in MxiC is
involved in controlling the secretion hierarchy. The conserva-
tion of the components involved indicates the importance of
this regulatory pathway to T3SS-carrying bacterial pathogens
of animals.
Experimental Procedures
Bacterial Strains, Plasmids, and Primers
The supplemental Tables S1 and S2 list the strains and plas-
mids used. S. flexneri strains were grown in Trypticase Soy
Broth (BD Biosciences) at 37 °C with appropriate antibiotics
the following final concentrations: ampicillin 100 g ml1,
kanamycin 50 g ml1, tetracycline 5 g ml1, and chloram-
phenicol 10gml1. IPTGwas used at the final concentrations
indicated in the figure legends. The supplemental Table S3 lists
the primers used.
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Plasmids were generated as described below and verified by
sequencing.
pIMA221 (pWSK29*mxiC) was generated by amplifying
mxiC from the Shigella virulence plasmid pWR100 using prim-
ers mxiC_SacI and mxiC_BamHI. The purified PCR product
was digested with SacI and BamHI and cloned into pWSK29*
(modified pWSK29 (45) lacking the T7 promoter, a gift from
Andrew Davidson (University of Bristol) digested with the
same enzymes.
Terminal Deletions andMutations—To express the terminal
mxiC deletions, mxiC was amplified from pIMA221 using
primers mxiC_SacI_del30 and mxiC_BamHI formxiCNterm
and primers mxiC_SacI and mxiC_341 for mxiC(1–341). The
resulting PCR products were digested with SacI and BamHI.
Fragments mxiCNterm and mxiC(1–341) were cloned into
pACT3 digested with SacI/BamHI yielding pDR60 and pDR73,
respectively.
Chaperone-bindingDomainMutants—pDR80containsmxiC
CBD, an internal deletion mutant that was created by two-step
PCR and lacks residues 32–72. The mxiC gene was amplified
from pIMA208 using primer pairs mxiC_SacI/mxiC_D32–
72_R and mxiC_D32–72_F/mxiC_BamHI. The obtained PCR
fragments were used as template for the second PCR step using
primers mxiC_SacI and mxiC_BamHI. The PCR product was
purified, digested with SacI/BamHI, and ligated into pACT3
digested with the same enzymes.
Mutant mxiCK66E was generated by two-step PCR. First,
mxiC was amplified from pIMA208 using primers mxiC_SacI
and mxiC_K66E_R and/or mxiC_K66E_F and mxiC_BamHI,
respectively. These fragments were combined and reamplified
using mxiC_SacI and mxiC_BamHI. The PCR products were
purified, digested with SacI and BamHI, and cloned into
pACT3 digested with the same enzymes yielding pDR96.
pDR100 contains mxiCK68E cloned via SacI/BamHI, equiva-
lent to amplification of mutantmxiC using primers mxiC_SacI
and mxiC_BamHI. This mutant was obtained by chance and
retained as the mutation was in a relevant area of the molecule.
Hydrophobic Patch Mutant—Double mutant mxiC(M226K,
L242D) was generated by two-step PCR. pIMA212 was used as
template for reactions with primer pairs mxiC_SacI/mxiC_
M226K_R and mxiC_L242D_F/mxiC_BamHI. The obtained
fragments were combined and reamplified using primers
mxiC_SacI and mxiC_BamHI. The product was purified,
digestedwith SacI andBamHI, and cloned into pACT3digested
with the same enzymes, yielding pDR72.
Hinge RegionMutants—Mutants in helix 9were generated by
two-step PCR; first, mxiC was amplified from pIMA208 using
primer pairs mxiC_SacI/mxiC_V256P_R, mxiC_V256P_F/
mxiC_BamHI, mxiC_SacI/mxiC_wobble_R, mxiC_wobble_F/
mxiC_BamHI, mxiC_SacI/mxiC_straight_R2, and mxiC_straight_
F2/mxiC_BamHI. The obtained PCR fragments were used as
template for the second PCR using primers mxiC_SacI and
mxiC_BamHI. The products were purified and digested with
SacI/BamHI before ligation into pACT3 digested with the
same enzymes. The resulting plasmids were named pDR91
(pACT3mxiCV256P), pDR92(pACT3mxiC(T253G,S254G,
D255G)), and pDR93(pACT3mxiC(I251A,T253A,S254A,
D255E)), respectively. The background quadruple cysteine
mutant gene mxiC(Cys) (C184A (TGT to GCA), C233S (TGT
to TCT), A247C (GCA to TGT), and S290C (AGT to TGT))
required for EPR experiments was synthesized by MWG
Eurofins and supplied as pEXA-mxiC_EPR2. For pDR104
(pET28bmxiC(Cys)), mxiC(Cys) was amplified from the pEX-A-
mxiC_EPR2 using primers mxiC_NdeI_F/mxiC_EcoRI_R. The
PCRproduct was purified and digestedwithNdeI/EcoRI before
cloning into pET28b (Novagen).
ChaperoneMutants
Deletions of the chaperone genes were performed using the
method of Datsenko and Wanner (46). A kanamycin cassette
was amplified from pKD4 using primers ipgA_KO_kanF/
ipgA_KO_kanR, ipgE_KO_kanF/ipgE_KO_kanR, and spa15_
KO_kanF/spa15_KO_kanR, respectively. The primers con-
tained 50 bp upstream and downstream of the respective
chaperone gene to allow for recombination by theRed recom-
binase. These fragments were introduced into Shigella wild
type yieldingipgA,ipgE, andspa15, respectively. ForipgE
spa15 (abbreviation of ipgE::FRT spa15::kan) and ipgE
ipgA (abbreviation ofipgE::FRTipgA::kan), the kanamycin
cassette was removed in ipgE by FLP-mediated recombina-
tion using the introduced FRT sites yielding ipgE::FRT. The
same fragments used for the deletion of spa15 and ipgA in the
wild-type background were now used for  Red recombination
in ipgE::FRT. This step was of low efficiency as the recombi-
nation preferentially occurred at the FRT scar at the ipgE site
and not up- and downstream of spa15 and ipgA, respectively.
Colonies were prescreened by colony PCR using primers
annealing200–300 bp upstream and downstreamof the orig-
inal chaperone gene, seeking to obtain a PCR fragment with a
size compatible with the insertion of the kanamycin cassette
versus the chaperone gene. ipgE ipgA spa15 (abbreviation
of ipgE::FRT ipgA::FRT spa15::kan) was generated by
removing the kanamycin cassette in ipgE ipgA by FLP
recombination yielding ipgE::FRT ipgA::FRT and subse-
quent  Red recombination using the ipgA::kan PCR frag-
ment. Again, this step was of low efficiency as now two FRT
sites were available on the virulence plasmid and colonies
were prescreened by colony PCR as described for the double
knockouts. All insertions and cassette removals were veri-
fied by sequencing.
Combination ofmxiC andmxiHMutants
Some of the mxiC plasmids detailed above were then com-
bined with plasmids carryingmxiHK69A or wild-typemxiH as
control in mxiCmxiH (12). mxiH and mxiHK69A were
amplified from corresponding templates (16), using primers
mxiH_NdeI_For and mxiH_PstI_Rev, and cloned into a previ-
ously described pUC18 vector, modified to carry a constitutive
lac operator (14). This was done so when both pACT3 contain-
ing mxiC and pUC18 containing mxiH were transformed into
mxiCmxiH bacteria, mxiH expression would not be inhib-
ited by LacI, encoded on pACT3, binding to the lac operator of
pUC18. The corresponding bacteria had normal expression of
mxiH and mxiC in the presence of 25 M IPTG except
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mxiCmxiH/mxiCNterm mxiH wild-type or K69A when
100 M IPTG was used to ensure sufficient expression of this
mxiCmutant.
Type III Secretion Functional Assays
Analysis of Protein Expression Levels—Whole cultures of
S. flexneri in late exponential phase (A6001) were mixed with
4 Laemmli sample buffer (“whole culture lysates”). Samples
from equivalent cell numbers (3 106 cfu) were separated by
10% SDS-PAGE and immunoblotted.
Analysis of Leakage—S. flexneri strains grown to A600 1
were collected by centrifugation at 15,900 g for 10min at 4 °C.
The supernatants were mixed with 4 Laemmli sample buffer,
normalized for equivalent cell numbers, separated on 10%SDS-
PAGE, and visualized by silver staining or immunoblotting. On
silver-stained SDS-PAGE, labels indicate the position of pro-
teins as determined by mass spectrometry or from deletion
strains.
Analysis of Inducible Protein Secretion—CR, a small am-
phipathic dye molecule, is an artificial inducer of T3S. Its
addition to a Shigella culture leads to a burst of Ipa protein
secretion called “induction” (47, 48). S. flexneri at A6001 was
collected by centrifugation at 4500 g and resuspended in PBS
to an A600 of 5, i.e. 1.5  109 cfu ml1. For each strain, two
reaction tubes were prepared with 500 l of bacterial suspen-
sion. To one of the tubes, CR (Serva) was added to a final con-
centration of 200gml1. After incubation at 37 °C for 15min,
samples were centrifuged at 15,900 g for 10min at 4 °C. 20l
of the supernatants denatured in Laemmli sample buffer were
subjected to 10% SDS-PAGE and visualized by silver staining or
immunoblotting.
Western Blotting
Proteins were transferred onto Immobilon FL (Millipore)
membrane using a semi-dry method. Primary antibodies used
were as follows: anti-IpaAmousemonoclonal, gift fromKirsten
Niebuhr (3); anti-IpaB mouse monoclonal, named H16, gift
from Armelle Phalipon (49); anti-IpaC mouse monoclonal,
mixture of J22 and K24, gift from Armelle Phalipon (50); anti-
IpaD rabbit polyclonal, gift from Claude Parsot (51) or as
described in Cheung et al. (14); anti-IpgD mouse monoclonal,
gift fromKirsten Niebuhr (3); and anti-MxiC rabbit polyclonal,
raised against a fragment of MxiC containing residues 74–355
and an N-terminal His tag (12). Near-infrared fluorescent sec-
ondary antibodies (rabbit IgG raised in goat and coupled to
Alexa680, Invitrogen; mouse IgG raised in goat and coupled to
DyLight800, Pierce) were visualized and quantified on a LI-
COR Odyssey imaging system.
Calculation of the Secreted Percentage of a Protein
Wild-type Shigella were grown to A6001 and resuspended
in PBS to anA600 of 15. The suspension was brought to 37 °C in
awater bath beforeCRwas added at a final concentration of 200
g ml1, and the cultures were incubated for 8 min. For
secreted proteins, sampleswere centrifuged at 15,000 g for 10
min at 4 °C, and supernatants were denatured in Laemmli sam-
ple buffer. For whole cultures, the bacterial suspension was
directly denatured in sample buffer. To calculate the secreted
percentage of each protein, we compared protein amounts in
supernatants and whole cultures by Western blotting. Undi-
luted and 1:4 diluted supernatant was compared with a dilution
series of the whole cultures. Near-infrared fluorescent second-
ary antibodies were quantified on a LI-COR Odyssey imaging
system.A linear fit of the dilution series allowedus to determine
the concentration of protein in the supernatant in comparison
with the whole culture.
EPR Spectroscopy
Modeling of the Bent MxiC Structure—To create a model of
the putative bent form of MxiC, its straight crystal structure
(PDB code 2VJ4 (21)) and the structure of YopN/TyeA (PDB
code 1XL3, Schubot et al. (20)) were used. In a first step, MxiC
was superimposed on YopN and TyeA independently. The
majority of the first two X-bundle domains of MxiC (residues
64–253) werematched to YopN, and the C-terminal domain of
MxiC (residues 254–355) was matched to TyeA. In the second
step, the respective MxiC domains were taken, and the link
between them (residues 250–260) was rebuiltmanually, guided
by the conformation of the equivalent region in YopN. This
model was soaked in a 1-nm layer of water molecules and
relaxed with 5000 steps of energy minimization under the Cvff
force field. Insight II 2005 was used for the modeling and Dis-
cover 2.98 (both Accelrys Inc.) for the energy calculations.
Modeling of Interspin Distances—The spin labelMTSL is rel-
atively long and flexible: the linker to the protein backbone
contains five dihedral angles. Thus, depending on the rotameric
state of each spin label in a protein, the interspin distance can
vary significantly. When bound to a protein, the spin label’s
rotamers have different energies due to their interactions with
the neighboring side-chains of the protein. The most favorable
rotamers and thus the most likely distance distribution were
calculated using MMM version 2013, a Matlab package (35).
We used eight different MxiC structures to calculate the inter-
spin distance distribution; the bent MxiC model and all seven
MxiC crystal structures from Deane et al. (21) (PDB codes
2VIX, 2VJ4, and 2VJ5) were extracted so that only a single poly-
peptide chain was present in each PDB file. This was necessary
as the labeled residues (247 and 290) are in close proximity to
the other polypeptide chains in the original PDB files. The
neighboring chains thus also influence the rotamer modeling;
however, MxiC is most likely monomeric in solution (21), and
therefore these additional interactions are not meaningful and
were excluded.
Protein Purification—Each protein was purified first by
nickel affinity chromatography and then by size-exclusion
chromatography. The protocols for these purifications were
based on articles herewith: Spa15 (53); IpgC/IpaC (39); and
MxiC(C184A/C233S/S243C/S290C) (21). For IpaD, a C322S
mutant was used to avoid the requirement for DTT addition
during the purification (54). For this, His6-IpaD(15–332)C322S
was amplified from pUC18 ipaDC322S (14), using primers
ipaD15_NdeI_For and ipaD_BamHI_Rev (supplemental Table
S3), and cloned into pET15b (Novagen) via NdeI/BamHI. The
changes to the protocol for each protein are detailed in supple-
mental Table S4.
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All protein concentrations, measured with a Nanodrop Lite
spectrophotometer (Thermo Scientific), were adjusted using
molecular weight, extinction coefficient (as obtained from the
ExPASy server) of the protein, and consideration of the path
length. Prior to each protein purification, the appropriate bac-
terial strain was streaked out on an Lysogeny Broth (LB) agar
plate containing the appropriate antibiotics and grown over-
night at 37 °C. The next day small LB cultures were made over-
night. In the morning, cultures were made with overnight cul-
tures (supplemental Table S4). Bacteria were grown to an A600
of0.6 before cooling to 20 °C and induction with a final con-
centration of 1 mM IPTG. Cultures were then left shaking at
20 °C overnight.
Cells were harvested by centrifugation (5000 g for 15min),
washed in 10 ml of PBS (3500 g for 5 min), and resuspended
with 30 ml of Binding buffer with protease inhibitors (Com-
plete EDTA-free, Roche Applied Science). Bacteria were lysed
by sonication (Sonics Vibra CellTM) at amplitude 60%, pulse 1-s
on and 1-s off, time of 30 s, and variable cycle numbers (supple-
mental Table S4).
Lysates were clarified by centrifugation for 30 min at
20,000  g at 4 °C. Supernatants were filtered through a
0.45-m and then 0.22-m syringe filter (Sartorius) and
applied to a 5-ml HisTrap FF column (GE Healthcare) equili-
brated in binding buffer (supplemental Table S4) using a peri-
staltic pump (GE Healthcare). The entire supernatant was
passed over the column three times at 2.5–5 ml/min at 4 °C.
The column was then connected to an A¨KTA (GE Healthcare)
and washed with 10–15 column volumes of Binding buffer,
followed by elution buffer (supplemental Table S4). Elution of
bound proteins was carried out in the presence of protease
inhibitors, with an imidazole gradient from 20 mM to 1 M (Elu-
tion buffer; supplemental Table S4) to 3 ml/min for 25 min.
5-ml fractions were collected. Peak fractions potentially con-
taining proteins of interest had their concentration determined
atA280 andwere examined using Coomassie-stained SDS-poly-
acrylamide gels. The appropriate fractions were pooled and
concentrated usingAmiconUltra spin concentrator (molecular
cutoff, Millipore; supplemental Table S4).
These concentrated fractions were run on a Superdex75
10/30 size exclusion chromatography column (GE Healthcare)
equilibrated in 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, and
100–250-l samples were applied, and the column was run
at 0.5 ml/min collecting 1-ml fractions. Location and purity
of proteins of interest were verified by Coomassie-stained
SDS-PAGE. After the final gel filtration step, all samples
were concentrated as above (supplemental Table S4) and
flash-frozen in aliquots in liquid nitrogen and stored at
80 °C until use.
MxiC Labeling—1 mM freshly made DTT (Sigma) was added
toMxiC(C184A/C233S/A247C/S290C) to reduce the SHof the
cysteines before concentration and application on the gel filtra-
tion column. The fractions containing His-MxiC(C184A/
C233S/A247C/S290C) (2.12 mg/ml) were pooled, and the
spin label MTSL (Toronto Research Chemicals, Toronto, Can-
ada) was added at 2-fold molar excess (121 M). This means
one molecule of MTSL was added per cysteine in the sample.
After incubation for overnight at 4 °C in the dark, the sample
was concentrated to1.842mM (70mg/ml) as determined by
the A280 using Amicon Ultra-4 spin concentrators (10-kDa
molecular mass cutoff, Millipore).
Determination of the Spin Concentration and Labeling Effi-
ciencyUsingContinuousWave EPR—Todetermine the labeling
efficiency of His-MxiC(Cys) withMTSL, continuous wave EPR
spectra were detected at room temperature on an E500 Elexsys
Bruker spectrometer equipped with a super high Q cavity. The
samples were thawed on ice, and 20 l were transferred into a
1.5-mm outer diameter glass capillary. A 14-mT field sweep
was performed, with 0.15 mTmodulation amplitude, 7.96 mil-
liwatt incident microwave power, and 9.38 GHz frequency.
As themeasured signal is the first derivative, the resulting curve
has to be integrated to obtain the absorbance spectrum.Double
integration yields the spin concentration as horizontal asymp-
tote. The area under the absorbance spectrum is proportional
to the spin concentration. The correlation factor was experi-
mentally determinedwith a solution of known concentration of
tempol in water.
Distance Measurement Using DEER—In this work, the
Q-band DEER experiments were performed as described in
Polyhach et al. (56). By using deuterated cryoprotectants, the
relaxation time can be increased thus increasing range of
distance measurement and sensitivity. As protein samples
are analyzed at 50 K after flash-freezing in liquid nitrogen,
the equilibrium population was observed, thus yielding a dis-
tance distribution rather than a single distance. For DEER,
the sample was thawed on ice, and 50 l was transferred into
a quartz tube (3 mm outer diameter, Aachener Quarz-Glas
Technologie Heinrich) and flash-frozen in liquid nitrogen.
Optimization and evaluation of Q-band DEER experiments
are described in Bordignon and Polyhach (57). Data were
acquired for 4–12 h. Normalized experimental data (V(t) 	
V(0)) are background corrected to obtain the DEER form
factor (F(t) 	 F(0)) by division by the background function
(which is mainly due to intermolecular interactions). The
form factor oscillates around a horizontal line at (1) ( is
the modulation depth) after background correction. The dis-
tance distribution is extracted from the form factor using
DeerAnalysis2013 (55).
Analysis of Interactions between MxiC and Other Proteins
Using EPR—To analyze the interaction between MxiC and
other proteins, we performed continuous wave X-band EPR
spectroscopy at room temperature to detect eventual changes
in the dynamic properties of the two spin labels on MxiC upon
complex formation. Each EPR sample was prepared in gel fil-
tration buffer (20 mM Tris-HCl, pH 7.5, 100 mM NaCl), and
contained a final concentration of 75 M MxiC and 10-fold
more of the other proteins (750 M).
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